MedPath

山东孔府制药有限公司

Ownership
-
Established
1992-04-22
Employees
-
Market Cap
-
Website
www.kfpc.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

43

NMPA:43

Drug Approvals

Ambrisentan Tablets

Product Name
安立生坦片
Approval Number
国药准字H20223343
Approval Date
May 31, 2022
NMPA

Erlotinib Hydrochloride Tablets

Product Name
盐酸厄洛替尼片
Approval Number
国药准字H20223186
Approval Date
Mar 29, 2022
NMPA

黄连上清片

Approval Number
国药准字Z20073041
Approval Date
Jan 16, 2020
NMPA

元胡止痛片

Approval Number
国药准字Z37021289
Approval Date
Jan 15, 2020
NMPA

黄连上清片

Approval Number
国药准字Z37020236
Approval Date
Jan 15, 2020
NMPA

牛黄解毒片

Approval Number
国药准字Z37020239
Approval Date
Jan 15, 2020
NMPA

板蓝根颗粒

Approval Number
国药准字Z37020228
Approval Date
Jan 15, 2020
NMPA

马钱子散

Approval Number
国药准字Z37020221
Approval Date
Jan 15, 2020
NMPA

风热感冒颗粒

Approval Number
国药准字Z37020003
Approval Date
Jan 14, 2020
NMPA

柏子养心片

Approval Number
国药准字Z37020222
Approval Date
Jan 14, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.